RP Bio Inc. (KOSDAQ:314140)
6,740.00
+80.00 (1.20%)
At close: Mar 6, 2026
30.37% (1Y)
| Market Cap | 58.41B +31.1% |
| Revenue (ttm) | 134.21B +4.7% |
| Net Income | 4.89B |
| EPS | 564.30 |
| Shares Out | 8.67M |
| PE Ratio | 11.94 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,501 |
| Average Volume | 27,796 |
| Open | 6,660.00 |
| Previous Close | 6,660.00 |
| Day's Range | 6,530.00 - 6,750.00 |
| 52-Week Range | 4,765.00 - 9,130.00 |
| Beta | 0.55 |
| RSI | 47.55 |
| Earnings Date | n/a |